Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $6,479 - $7,209
-31 Reduced 7.13%
404 $88,000
Q4 2023

Feb 08, 2024

BUY
$197.69 - $227.29 $12,652 - $14,546
64 Added 17.25%
435 $98,000
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $2,211 - $2,438
11 Added 3.06%
371 $74,000
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $43,233 - $49,231
-204 Reduced 36.17%
360 $86,000
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $44,583 - $53,886
-209 Reduced 27.04%
564 $129,000
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $78,024 - $95,355
383 Added 98.21%
773 $181,000
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $204 - $262
-1 Reduced 0.26%
390 $80,000
Q2 2022

Aug 09, 2022

BUY
$213.86 - $277.87 $19,461 - $25,286
91 Added 30.33%
391 $92,000
Q1 2022

May 06, 2022

SELL
$259.82 - $298.18 $10,132 - $11,629
-39 Reduced 11.5%
300 $80,000
Q4 2021

Feb 01, 2022

SELL
$271.6 - $314.21 $10,864 - $12,568
-40 Reduced 10.55%
339 $107,000
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $2,748 - $3,083
10 Added 2.71%
379 $107,000
Q2 2021

Aug 09, 2021

BUY
$251.87 - $278.14 $21,660 - $23,920
86 Added 30.39%
369 $102,000
Q1 2021

May 12, 2021

BUY
$204.88 - $255.03 $3,278 - $4,080
16 Added 5.99%
283 $72,000
Q4 2020

Feb 16, 2021

SELL
$186.91 - $214.42 $4,485 - $5,146
-24 Reduced 8.25%
267 $54,000
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $501 - $603
3 Added 1.04%
291 $55,000
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $104,811 - $168,757
-925 Reduced 76.26%
288 $48,000
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $7,823 - $14,646
75 Added 6.59%
1,213 $155,000
Q4 2019

Feb 03, 2020

BUY
$163.48 - $173.61 $21,579 - $22,916
132 Added 13.12%
1,138 $184,000
Q3 2019

Oct 24, 2019

BUY
$159.77 - $178.1 $61,830 - $68,924
387 Added 62.52%
1,006 $163,000
Q2 2019

Jul 24, 2019

BUY
$144.16 - $172.9 $7,063 - $8,472
49 Added 8.6%
619 $101,000
Q1 2019

Apr 29, 2019

BUY
$123.7 - $156.3 $49,356 - $62,363
399 Added 233.33%
570 $81,000
Q4 2018

Jan 17, 2019

BUY
$120.82 - $174.09 $6,282 - $9,052
52 Added 43.7%
171 $15,000
Q3 2018

Oct 29, 2018

SELL
$167.67 - $188.27 $167 - $188
-1 Reduced 0.83%
119 $18,000
Q2 2018

Aug 09, 2018

SELL
$160.33 - $189.41 $480 - $568
-3 Reduced 2.44%
120 $18,000
Q1 2018

May 10, 2018

SELL
$161.53 - $178.11 $18,252 - $20,126
-113 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$147.99 - $163.95 $2,663 - $2,951
18 Added 18.95%
113 $13,000
Q3 2017

Oct 13, 2017

BUY
$149.47 - $160.56 $6,128 - $6,582
41 Added 75.93%
95 $12,000
Q2 2017

Aug 15, 2017

BUY
N/A
54
54 $6,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.